Starreveld, Daniëlle E. J.
Daniels, Laurien A.
Valdimarsdottir, Heiddis B.
Redd, William H.
de Geus, Jessie L.
Ancoli-Israel, Sonia
Lutgendorf, Susan
Korse, Catharina M.
Kieffer, Jacobien M.
van Leeuwen, Flora E.
Bleiker, Eveline M. A.
Funding for this research was provided by:
KWF Kankerbestrijding (NKI 2015-7909)
Article History
Received: 6 August 2018
Accepted: 14 August 2018
First Online: 10 September 2018
Ethics approval and consent to participate
: This study (NL 61017.031.17) has received ethical approval from the Institutional Review Board of The Netherlands Cancer Institute (METC-AVL), reference number M17SPA) on May 9th 2017 as a multi-center study. Amendments are changes made to the research after approval by the accredited METC has been given. All amendments will be notified to the METC that gave approval.Participating hospitals are Admiraal de Ruyter hospital (Goes), Albert Schweitzer hospital (Dordrecht), Erasmus Medical Center (Rotterdam), Haga Hospital (The Hague), Leiden University Medical Center (Leiden), Radboud University Medical Center (Nijmegen), The Netherlands Cancer Institute (Amsterdam), University Medical Center Utrecht (Utrecht), VU University Medical Center (Amsterdam).A written informed consent is obtained from all participants upon participation.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.